Kevin E. Weddington

Array ( [id] => 6706847 [patent_doc_number] => 20030153581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Stabilized difloxacin injectable solution' [patent_app_type] => new [patent_app_number] => 10/346597 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2077 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153581.pdf [firstpage_image] =>[orig_patent_app_number] => 10346597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1031196 [patent_doc_number] => 06878749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-12 [patent_title] => 'Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes' [patent_app_type] => utility [patent_app_number] => 10/345908 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18919 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878749.pdf [firstpage_image] =>[orig_patent_app_number] => 10345908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7619916 [patent_doc_number] => 06943267 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-13 [patent_title] => 'Thiophosphonate inhibitors of phosphatase enzymes and metallophosphatases' [patent_app_type] => utility [patent_app_number] => 10/346672 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12922 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943267.pdf [firstpage_image] =>[orig_patent_app_number] => 10346672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026842 [patent_doc_number] => 20050020614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof' [patent_app_type] => utility [patent_app_number] => 10/501210 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8643 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020614.pdf [firstpage_image] =>[orig_patent_app_number] => 10501210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851057 [patent_doc_number] => 20030143260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Method for supplying bioavailable methionine to a cow' [patent_app_type] => new [patent_app_number] => 10/336912 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5734 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143260.pdf [firstpage_image] =>[orig_patent_app_number] => 10336912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1170581 [patent_doc_number] => 06749864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-15 [patent_title] => 'Stabilized pharmaceutical composition' [patent_app_type] => B2 [patent_app_number] => 10/335421 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9928 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/749/06749864.pdf [firstpage_image] =>[orig_patent_app_number] => 10335421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999629 [patent_doc_number] => 06911480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => 'Methods for the inhibition of exoprotein production from Gram positive bacteria' [patent_app_type] => utility [patent_app_number] => 10/330156 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8444 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911480.pdf [firstpage_image] =>[orig_patent_app_number] => 10330156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1050170 [patent_doc_number] => 06861449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-01 [patent_title] => 'Method of treating neutrophil-related diseases with topical anesthetics' [patent_app_type] => utility [patent_app_number] => 10/326224 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8101 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861449.pdf [firstpage_image] =>[orig_patent_app_number] => 10326224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684003 [patent_doc_number] => 20030119867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria' [patent_app_type] => new [patent_app_number] => 10/325521 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3747 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119867.pdf [firstpage_image] =>[orig_patent_app_number] => 10325521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6808670 [patent_doc_number] => 20030198609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression' [patent_app_type] => new [patent_app_number] => 10/239073 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10155 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20030198609.pdf [firstpage_image] =>[orig_patent_app_number] => 10239073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6652003 [patent_doc_number] => 20030105127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Methods of use of gemifloxacin compounds against fluoroquinolone resistant streptococcus pneumoniae bacteria' [patent_app_type] => new [patent_app_number] => 10/323101 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2911 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105127.pdf [firstpage_image] =>[orig_patent_app_number] => 10323101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861742 [patent_doc_number] => 20030092750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor' [patent_app_type] => new [patent_app_number] => 10/322982 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3498 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092750.pdf [firstpage_image] =>[orig_patent_app_number] => 10322982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1046856 [patent_doc_number] => 06864251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-08 [patent_title] => 'Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines' [patent_app_type] => utility [patent_app_number] => 10/309573 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16477 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864251.pdf [firstpage_image] =>[orig_patent_app_number] => 10309573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787177 [patent_doc_number] => 20030138416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Use of glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes' [patent_app_type] => new [patent_app_number] => 10/308355 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9701 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138416.pdf [firstpage_image] =>[orig_patent_app_number] => 10308355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411407 [patent_doc_number] => 20040106601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines' [patent_app_type] => new [patent_app_number] => 10/309527 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12280 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106601.pdf [firstpage_image] =>[orig_patent_app_number] => 10309527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089812 [patent_doc_number] => 20050009925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure' [patent_app_type] => utility [patent_app_number] => 10/496765 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5377 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009925.pdf [firstpage_image] =>[orig_patent_app_number] => 10496765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788139 [patent_doc_number] => 20030139378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Liquid bisphosphonate formulations for bone disorders' [patent_app_type] => new [patent_app_number] => 10/305868 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15248 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139378.pdf [firstpage_image] =>[orig_patent_app_number] => 10305868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761961 [patent_doc_number] => 20030125323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Use of selective potassium channel openers' [patent_app_type] => new [patent_app_number] => 10/303297 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9747 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125323.pdf [firstpage_image] =>[orig_patent_app_number] => 10303297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658335 [patent_doc_number] => 20030078294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Methods and compositions for the treatment and prevention of lung disease' [patent_app_type] => new [patent_app_number] => 10/305049 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4171 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078294.pdf [firstpage_image] =>[orig_patent_app_number] => 10305049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697325 [patent_doc_number] => 20030109519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Use of selective potassium channel openers' [patent_app_type] => new [patent_app_number] => 10/303274 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9731 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109519.pdf [firstpage_image] =>[orig_patent_app_number] => 10303274 [rel_patent_id] =>[rel_patent_doc_number] =>)